KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Income from Continuing Operations (2016 - 2025)

Eli Lilly (LLY) has disclosed Income from Continuing Operations for 17 consecutive years, with 6637700000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 50.52% year-over-year to 6637700000.0, compared with a TTM value of 20640000000.0 through Dec 2025, up 94.9%, and an annual FY2025 reading of 20640000000.0, up 94.9% over the prior year.
  • Income from Continuing Operations was 6637700000.0 for Q4 2025 at Eli Lilly, up from 5582500000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 6637700000.0 in Q4 2025 and bottomed at 57400000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is 2414825000.0, with a median of 1833050000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations tumbled 103.95% in 2023, then soared 1790.42% in 2024.
  • Year by year, Income from Continuing Operations stood at 1726100000.0 in 2021, then rose by 12.26% to 1937700000.0 in 2022, then increased by 12.98% to 2189300000.0 in 2023, then skyrocketed by 101.43% to 4409800000.0 in 2024, then soared by 50.52% to 6637700000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for LLY at 6637700000.0 in Q4 2025, 5582500000.0 in Q3 2025, and 5660500000.0 in Q2 2025.